Type 2 diabetes (T2DM) is characterized by elevated fasting and postprandial plasma glucose concentrations, which result from increased endogenous glucose production (EGP), decreased insulin-mediated muscle glucose disposal, and suppression of endogenous glucose release, and inadequate pancreatic insulin secretion [1]. The gene discussed is INS; the disease is type 2 diabetes mellitus.